According to AJ Triano, SVP Engagement Strategy at GSW, "the industry must work harder to co-create and socialize all its learnings, techniques, and codes with regard to AI, which means sharing data with each other in real time."
See more of AJ's thoughts on AI adoption and its potential for use in drug discovery and pharmacovigilance in PharmaVOICE's May issue, in Artificial Intelligence and Machine Learning.
This content is repurposed from PharmaVOICE.
